Cleared Traditional

K222975 - Advantis Platform (FDA 510(k) Clearance)

Mar 2023
Decision
154d
Days
Class 2
Risk

K222975 is an FDA 510(k) clearance for the Advantis Platform. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Advantis Medical Imaging Single Member P.C. (Athens, GR). The FDA issued a Cleared decision on March 1, 2023, 154 days after receiving the submission on September 28, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K222975 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2022
Decision Date March 01, 2023
Days to Decision 154 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050